WordNet

PrepTutorEJDIC

《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
(手術による器官や組織,特に骨の)切徐
卵巣の / 子房(しぼう)の
OLD French古[代]フランス語

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 女性の不妊症に対する不妊手術 reproductive surgery for female infertility
2. 多嚢胞性卵巣症候群における排卵誘発のための腹腔鏡下手術 laparoscopic surgery for ovulation induction in polycystic ovary syndrome
3. 成人における多嚢胞性卵巣症候群の治療 treatment of polycystic ovary syndrome in adults
4. 卵巣莢膜細胞過形成 ovarian hyperthecosis
5. 成人における多嚢胞性卵巣症候群の診断 diagnosis of polycystic ovary syndrome in adults

Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor.

Arnaoutakis DJ1, Kim Y, Pulitano C, Zaydfudim V, Squires MH, Kooby D, Groeschl R, Alexandrescu S, Bauer TW, Bloomston M, Soares K, Marques H, Gamblin TC, Popescu I, Adams R, Nagorney D, Barroso E, Maithel SK, Crawford M, Sandroussi C, Marsh W, Pawlik TM.
Annals of surgery.Ann Surg.2015 Feb;261(2):361-7. doi: 10.1097/SLA.0000000000000543.
OBJECTIVE: To characterize clinical and radiological features associated with biliary cystic tumors (BCTs) of the liver, and to define recurrence-free and overall survival.BACKGROUND: Biliary cystadenoma (BCA) and biliary cystadenocarcinoma (BCAC) are rare tumors that arise in the liver.METHODS: Bet
PMID 24509187

Gemcitabine-based regimen for primary ovarian angiosarcoma with MYC amplification.

Yonezawa I1, Waki M2, Tamura Y1, Onoda R1, Narushima M1, Ishizuka T1, Tajima S3.
Current oncology (Toronto, Ont.).Curr Oncol.2014 Dec;21(6):e782-9. doi: 10.3747/co.21.2144.
Angiosarcoma is a rare and aggressive type of sarcoma, and primary angiosarcoma of the ovary is extremely rare. We report the case of a 29-year-old woman who was diagnosed with ovarian angiosarcoma and possible bone metastases. We treated this patient with a gemcitabine-based regimen as postoperativ
PMID 25489268

Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.

Usami T1, Kato K, Taniguchi T, Abe A, Nomura H, Yamamoto A, Matoda M, Okamoto S, Kondo E, Omatsu K, Kawamata Y, Takeshima N.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.Int J Gynecol Cancer.2014 Jul;24(6):991-6. doi: 10.1097/IGC.0000000000000142.
OBJECTIVES: Similar to primary debulking surgery, complete resection of all macroscopic diseases during interval debulking surgery (IDS) is the primary objective while using neoadjuvant chemotherapy followed by IDS for advanced ovarian, fallopian tube, and peritoneal cancers. However, most patients
PMID 24905612